Clinical Trials Directory

Trials / Completed

CompletedNCT00926939

Technological Innovations in Behavioral Treatments for Cigarette Smoking

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
National Development and Research Institutes, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.

Detailed description

Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed

Conditions

Interventions

TypeNameDescription
BEHAVIORALReinforcement for the abstinence of smokingParticipants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.
BEHAVIORALReinforcement for submission of videos with CO sampleThis intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.

Timeline

Start date
2009-06-01
Primary completion
2014-05-01
Completion
2014-08-01
First posted
2009-06-24
Last updated
2015-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00926939. Inclusion in this directory is not an endorsement.